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Abstract Mass spectrometric methods were used to investigate
the proteolytic processing and glycopeptide structures of three
seed defensive proteins from Phaseolus vulgaris. The proteins
were the K-amylase inhibitors KAI-1 and KAI-2 and arcelin-5, all
of which are related to the seed lectins, PHA-E and PHA-L. The
mass data showed that the proteolytic cleavage required for
activation of the amylase inhibitors is followed by loss of the
terminal Asn residue in KAI-1, and in all three proteins, seven or
more residues were clipped from the C-termini, in the manner of
the seed lectins. In most instances, individual glycoforms could be
assigned at each Asn site, due to the unique masses of the plant
glycopeptides. It was found that KAI-1 and KAI-2 differed
significantly in their glycosylation patterns, despite their high
sequence homology. These data complement the previous X-ray
studies of the K1-amylase inhibitor and arcelin, where many of
the C-terminal residues and glycopeptide residues could not be
observed.
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1. Introduction
Seeds of legume plants contain in addition to their well-
known lectins other proteins that show sequence homology
to the lectins but do not bind carbohydrates. In the common
bean, Phaseolus vulgaris, several of these lectin-like proteins
have been identi¢ed [1], and have been shown to function as
defensive proteins [2]. They include two inhibitors of insect
gut K-amylases, KAI-1 and KAI-2, and a small group of pro-
teins termed arcelins, that are only found in some wild acces-
sions of the common bean. The major interest in these pro-
teins is that they can be used to produce insect resistant
transgenic plants [3]. The proteins show deletions in some of
the loops that form the carbohydrate binding site in the ho-
mologous P. vulgaris lectins PHA-E and PHA-L [4,5], and the
two amylase inhibitors also undergo an internal proteolytic
cleavage that is essential for their activity [6]. X-ray crystallo-
graphic studies have been reported on the complex of KAI-1
with porcine pancreatic amylase [7], arcelin-5 [8] and arcelin-1
[9], and PHA-L [10].
In the crystal structures, many C-terminal amino acid res-
idues and most of the sugar residues of the glycopeptides
could not be located in the electron density maps. Previous
mass spectrometric studies of legume lectins, including P. vul-
garis hemagglutinins, have shown that they undergo extensive
post-translational proteolysis at their C-termini [11,12]. We
report mass spectrometric experiments that show most of
the unlocatable C-terminal residues are in fact not present
in the mature molecules, and that the processing at the inter-
nal cleavage site in the amylase inhibitors is more extensive
than a simple scission of the polypeptide chain. The data also
allowed assignment of speci¢c glycoforms to the individual
Asn sites, aided by the simpler structures of plant N-linked
glycopeptides compared to their mammalian counterparts
[13,14]. For vacuolar plant glycoproteins, the species found
are high mannose forms of general formula Man5ÿ9GlcNAc2
and complex ones, Man3GlcNAc2Fuc0ÿ1Xyl0ÿ1, all of which
have unique molecular masses.
2. Materials and methods
2.1. Proteins and peptide preparations
The amylase inhibitors and arcelin-5 were prepared as previously
described [15]. Initial ES/MS experiments showed signi¢cant amounts
of a small (8^9 kDa) protein were present in some of the samples,
which were removed by size exclusion chromatography on Superdex
75 or reverse phase HPLC. The latter procedure was also used to
separate the two chains of the amylase inhibitors. Peptides were pre-
pared from the individual chains as previously described [16], includ-
ing cleavage at Asp residues by mild acid hydrolysis, further fragmen-
tation with trypsin and separation of the peptide digests by reverse
phase HPLC, including on-line LC/MS.
2.2. Mass spectrometry
Electrospray mass spectra were obtained with a PE-Sciex (Concord,
Ont.) API 300 instrument, and MALDI-TOF spectra were obtained
with a Perseptive Biosystems Elite-STR (Framingham, MA) using
linear mode. The matrix K-cyano cinnaminic acid (Aldrich) was
used for all MALDI-TOF analyses. Mass assignment was made using
external calibration and mass accuracy was found to be within þ 3 Da
of the predicted molecular weight. Nanoelectrospray mass spectra
were obtained using a modi¢ed MicroIonspray interface (PE-Sciex)
comprising a small tee insert used to establish electrical contact be-
tween a fused silica transfer line (80 cmU50 Wm i.d.) and the emitter
tip. Disposable nanoelectrospray emitters with no gold coating were
made of a small length of tapered fused silica, 5.3 cmU50 Wm i.d. with
a 5 Wm tip diameter, similar to those described previously [17]. Sam-
ples dissolved in 0.1 M HCOOH were infused to the mass spectrom-
eter at a £ow rate of approximately 200 nl/min using a pressurized
inlet device.
3. Results
3.1. KAI-1
The masses of the K and L chains of KAI-1 were measured
by MALDI-TOF/MS (Fig. 1a) and by ES/MS of the sepa-
rated chains. The major K-chain species had a mass of
11 646 Da. It has two glycosylation sites with reported major
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glycoforms of Man6GlcNAc2 and Man9GlcNAc2, from chem-
ical [18] or tandem mass spectrometric analyses [19]. Together
with the reported 1^77 sequence [20] these give a predicted
mass of 11 761 Da. The discrepancy of 115 Da suggested that
the C-terminal Asn-77 had also been removed proteolytically.
To con¢rm this and to assign the glycoforms to the respective
sites, peptides were prepared by mild acid cleavage at Asp
residues. Mass data and N-terminal sequencing con¢rmed
the sequence of the K-chain and that Asn-77 was not present
(Fig. 2). The peptide data also con¢rmed that Asn-12 carried
the Man6GlcNAc2 and related glycoforms, and Asn-65 car-
ried the Man9GlcNAc2 and its trimmed subspecies [19].
The L-chain mass was measured as 16 528 Da. Its dominant
single glycan was reported to be Man3GlcNAc2Xyl1 [18],
hence the calculated mass was 17 319 Da. The discrepancy
again suggested C-terminal processing, removing seven amino
acids after an Asn residue, which would give a calculated mass
of 16 527 Da. The L-chain sequence contains two possible
Asn-Xaa-Ser/Thr sites for glycosylation, Asn-63 and Asn-83
(Fig. 2). LC/MS peptide mapping of a mild acid and trypsin
double digest (data not shown) identi¢ed the site as Asn-63,
which is homologous with a site in KAI-2 [1]. This site was
identi¢ed in the subsequent X-ray structure [7] and the present
mass spectrometry data con¢rmed the glycan was predomi-
nantly the Man3GlcNAc2Xyl1 species [18].
3.2. KAI-2
Similar experiments to the above were carried out with the
second P. vulgaris amylase inhibitor to see if it had undergone
similar post-translational processing. A MALDI-TOF experi-
ment with material puri¢ed by size exclusion chromatography
showed two species of K-chain with two or three glycopeptide
chains respectively (Fig. 1b), consistent with the additional
site for N-glycosylation at Asn-69 compared to KAI-1. The
mass of the larger species with two major glycans, 11 014 Da,
is consistent with glycans of combined composition
Man11GlcNAc5Xyl1Fuc1, calculated mass 11 010 Da. Tandem
mass spectral analysis of a tryptic peptide 51^72,
containing both the Asn-63 and Asn-69 sequons, showed
that one of these carries a single GlcNac residue (data not
shown). The other glycan on this glycopeptide was
GlcNAc2Man3XylFuc0ÿ1. In the K-chain species with three
glycans, the single GlcNac is replaced by GlcNAc2Man9. Ho-
mology to KAI-1 suggests this should be assigned to Asn-63.
In contrast to the glycosylation of KAI-1, the predominant
species of KAI-2 L-chain had a mass of 15 353 Da, consistent
with a non-glycosylated L-chain truncated at the homologous
position to KAI-1, calculated mass 15 351 Da.
3.3. Arcelin-5
This protein is monomeric [8], does not undergo internal
cleavage, and its mode of toxic action is not known. There are
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Fig. 1. MALDI-TOF mass spectra of (a) KAI-1 and (b) KAI-2. Fig. 2. Sequences of KAI-1 [20] and KAI-2 [22] with the sequenced
peptides and the located cleavage (arrows) and glycopeptide sites
(diamonds). Glycan 1 was predominantly GlcNAc2Man6, glycan 2
was predominantly GlcNAc2Man9, and glycans 3 and 4 were pre-
dominantly GlcNAc2Man3Xyl. Peptides from mild acid cleavage at
Asp are shown with a single line above the KAI-1 sequence and
tryptic sub-peptides with a double line. The tryptic peptide with two
Asn sites from KAI-2, examined by tandem mass spectrometry, is
indicated with a dashed underline.
Fig. 3. Conventional ES/MS spectrum of arcelin-5 (a) and recon-
structed molecular mass pro¢le (b). The assigned C-terminal se-
quence from the two sets of peaks is described in Fig. 4.
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two closely related forms, arcelin-5a with three potential N-
glycosylation sites, and arcelin-5b with two sites [21], and it
was suggested that only two sites on 5a were substituted [21].
However, several C-terminal residues were not located in the
recent crystallographic work [8], pointing to possible C-termi-
nal truncation, and only one glycosylation site was identi¢ed,
at Asn-22. ES/MS measurements of the intact protein dis-
closed a complex set of components which could be resolved
into two sets, each comprised of species with di¡erent degrees
of C-terminal truncation (Fig. 3). The C-terminal sequence
could thus be read directly and matched to the reported
gene sequences which are identical in this region (Fig. 4).
This showed that both species were truncated around the
same point as the amylase inhibitors. The arcelin type was
assigned as 5a, based on a peptide consistent with the 5a
sequence for residues 44^49 [21] being found in tryptic peptide
mapping by LC/MS. The mass spectrometry data suggest
there are two glycans per chain, but exact attribution to in-
dividual glycoforms could not be made directly from these
data.
4. Discussion
By means of relatively simple mass spectrometric experi-
ments, it was possible to investigate simultaneously two as-
pects of the post-translational processing of these plant seed
glycoproteins, viz. glycosylation and proteolytic C-terminal
trimming. This was made possible by the simplicity and
unique masses of each of the possible plant glycans. The re-
sults are complementary to the recent crystallographic studies
of these proteins, which did not locate many residues involved
in the post-translational modi¢cations.
The proteolysis which leads to activation of KAI-1 is dem-
onstrated by the present mass spectrometric data to be more
complex than previously thought. Rather than a simple cleav-
age at the carboxyl side of Asn-77, presumably by the Asn-
speci¢c seed protease which seems to be generally important
in legume lectin processing [10,11], the Asn-79 is completely
removed, apparently by the action of a carboxypeptidase. In
the crystal structure of the porcine amylase complex with this
inhibitor [7], three residues were actually unassignable from
the electron density in this key active site region. The cleavage
occurs at a point which is close to that of a cis peptide bond
in legume lectin and arcelin [8] structures, at Ala-Asp and
Ala-Tyr sequences respectively. The cleavage may therefore
re£ect an alternative means to achieving the unusual confor-
mations required for the active form of members of this pro-
tein family. Furthermore, 19 residues at the C-terminus of the
L-chain of KAI-1 and 12 residues of arcelin were also not
locatable from their electron density maps [7,8]. The mass
data show that many of these residues are in fact not present
in the mature forms of the proteins. The third protein, KAI-2,
shows similar cleavages to KAI-1, but a somewhat di¡erent
glycosylation pattern.
The mass spectrometry data for the KAI-1 and its peptides
allowed further assignment of the reported glycoforms [16] to
individual Asn residues in the K- and L-chains. Though the
gene sequences of both inhibitors had been reported [20,22],
the sequences were re-determined by protein methods recently
[23,24]. The mass spectrometry data show that the latter ex-
periments did not give a complete sequence as short peptides
at each of the C-termini were overlooked (Fig. 4). Surprisingly
the glycan assignments show that the homology of the Asn
sequon locations in the two inhibitors does not lead to similar
glycopeptides, because of di¡erential glycan modi¢cation. The
additional site in KAI-2 at Asn-67, which is remarkably close
to the Asn-63 one, appears to in£uence the glycosylation of
the Asn-63. In some molecules, it has no glycan, in others it
carries a GlcNAc2Man9 and in a third set there appears to be
a single GlcNAc. The simplest way this could arise is by the
action of a seed endoglucosaminidase on the GlcNAc2Man9
species. In addition, the L-chain of KAI-2 was more rarely
glycosylated at the homologous Asn sequon than KAI-1. A
similar phenomenon has been observed in the bean storage
protein phaseolin, which has glycans at Asn-252 and Asn-341.
When both positions are glycosylated, both remain in the high
mannose form. When only Asn-252 is glycosylated, the high
mannose glycan is modi¢ed in the Golgi to become a complex
glycan [25]. These positions are close together in the three-
dimensional structure of phaseolin [26].
The C-terminal processing of several legume lectins has
been shown to be attributable to the combined actions of
an Asn-speci¢c seed protease and a carboxypeptidase
[11,12]. The lectin homologues studied here show very similar
processing patterns to PHA-E when the various sequences and
cleavage sites are aligned (Fig. 4). The C-terminal segment
appears to be highly susceptible to proteolysis since lectins
expressed in Escherichia coli also show C-terminal processing
from endogenous proteases [11]. This may be true of many
other proteins since accurate mass determination has only
recently become possible and is not yet routine in many pro-
tein laboratories. However, in crystallographic studies when
C-terminal residues are not detectable in the electron density,
a check to see if they are actually present in the protein,
whether recombinantly produced or not, is de¢nitely indi-
cated.
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